Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression

被引:8
|
作者
Li, Boru [1 ]
Xu, Meijing [1 ]
Wang, Yu [1 ]
Feng, Lijin [1 ]
Xing, Hang [1 ,2 ]
Zhang, Kuo [1 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang 110016, Peoples R China
[2] Jiangsu Kan Pharmaceut Co Ltd, Lianyungang 222001, Peoples R China
[3] Tianjin UBasio Biotechnol Grp, Tianjin 300457, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Traditional Chinese medicine; Gut microbiota; Depression; CHAIHU-SHUGAN-SAN; ARYL-HYDROCARBON RECEPTOR; TRIMETHYLAMINE-N-OXIDE; NEUROTROPHIC FACTOR; KYNURENINE PATHWAY; MAJOR DEPRESSION; BRAIN AXIS; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE;
D O I
10.1016/j.jep.2022.116038
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnic pharmacological relevance: The causes of depression are complex. Many factors are involved in its patho-genesis, including the individual's biological and social environment. Although numerous studies have reported that the gut microbiota plays a significant role in depression, drugs that regulate the gut microbiota to treat depression have not yet been comprehensively reviewed. At the same time, more and more attention has been paid to the characteristics of traditional Chinese medicine (TCM) in improving depression by regulating gut microbiota. In ancient times, fecal microbiota transplantation was recorded in TCM for the treatment of severe diseases. There are also records in Chinese ancient books about the use of TCM to adjust gut microbiota to treat diseases, which has opened up a unique research field in TCM. Therefore, this article focuses on the pharma-cological effects, targets, and mechanisms of TCM in improving depression by mediating the influence of gut microbiota.Aim of this review: To summarize the role the gut microbiota plays in depression, highlight potential regulatory targets, and elucidate the anti-depression mechanisms of TCMs through regulation of the gut microbiota. Methods: A systematic review of 256 clinical trials and pharmaceutical studies published until June 2022 was conducted in eight electronic databases (Web of Science, PubMed, SciFinder, Research Gate, ScienceDirect, Google Scholar, Scopus, and China Knowledge Infrastructure), according to the implemented PRISMA criteria, using the search terms "traditional Chinese medicine," "depression," and "gut microbiota."Results: Numerous studies reported the effects of different gut bacteria on depression and that antidepressants work through the gut microbiota. TCM preparations based on compound Chinese medicine, the Chinese Materia Medica, and major bioactive components exerted antidepressant-like effects by improving levels of neuro-transmitters, short-chain fatty acids, brain-derived neurotrophic factor, kynurenine, and cytokines via regulation of the gut microbiota.Conclusion: This review summarized the anti-depression effects of TCM on the gut microbiota, providing evidence that TCMs are safe and effective in the treatment of depression and may provide a new therapeutic approach.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Gut microbiota: A new target of traditional Chinese medicine for insomnia
    Feng, Wanying
    Yang, Zhihua
    Liu, Yangxi
    Chen, Rui
    Song, Zhihui
    Pan, Guiyun
    Zhang, Yuhang
    Guo, Zehui
    Ding, Xinya
    Chen, Lu
    Wang, Yi
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [2] The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer
    Chen, Yan-Zhen
    Yuan, Meng-Yun
    Chen, Ya Ling
    Zhang, Xingxing
    Xu, Xin-Tian
    Liu, Shen-Lin
    Zou, Xi
    Tao, Jia-Lei
    Qiang, Yong-Hu
    Wu, Jian
    Sun, Qing-Min
    [J]. CURRENT DRUG TARGETS, 2021, 22 (11) : 1222 - 1231
  • [3] Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
    Li, Jinfan
    Li, Dong
    Chen, Yajie
    Chen, Wenbin
    Xu, Jin
    Gao, Ling
    [J]. CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 963 - 986
  • [4] Gut microbiota as a target to limit toxic effects of traditional Chinese medicine: Implications for therapy
    Feng, Wuwen
    Liu, Juan
    Huang, Lihua
    Tan, Yuzhu
    Peng, Cheng
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [5] Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
    Tian-Yi Cheng
    Jia-Xin Li
    Jing-Yi Chen
    Pei-Ying Chen
    Lin-Rui Ma
    Gui-Lin Zhang
    Pei-Yu Yan
    [J]. Chinese Medicine, 16
  • [6] Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease
    Cheng, Tian-Yi
    Li, Jia-Xin
    Chen, Jing-Yi
    Chen, Pei-Ying
    Ma, Lin-Rui
    Zhang, Gui-Lin
    Yan, Pei-Yu
    [J]. CHINESE MEDICINE, 2021, 16 (01)
  • [7] Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota
    Zhou, Yaochuan
    Zhang, Dandan
    Cheng, Hao
    Wu, Jinlu
    Liu, Juan
    Feng, Wuwen
    Peng, Cheng
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [8] Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: A new perspective to understand traditional Chinese medicine
    Yue, Bingjie
    Zong, Gangfan
    Tao, Ruizhi
    Wei, Zhonghong
    Lu, Yin
    [J]. PHYTOTHERAPY RESEARCH, 2022, 36 (11) : 4125 - 4138
  • [9] Prevention and treatment of rheumatoid arthritis through traditional Chinese medicine: role of the gut microbiota
    Liang, Yujiao
    Liu, Mengyao
    Cheng, Yingxue
    Wang, Xinchang
    Wang, Weijie
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Advances in the treatment of diabetic peripheral neuropathy by modulating gut microbiota with traditional Chinese medicine
    Li, Ye-Yao
    Guan, Rui-Qian
    Hong, Zhi-Bo
    Wang, Yao-Lei
    Pan, Li-Min
    [J]. WORLD JOURNAL OF DIABETES, 2024, 15 (08)